Correlations of the expression of silencing information regulatory factor 2-related enzyme-1 and colony-stimulating factor 1 receptors with clinical features and prognosis in patients with colon cancer

XU Xinlong; LI Huan; MA Kaixuan

doi:10.7619/jcmp.20242568

Journal of Clinical Medicine in Practice > 2024 > 28(23): 70-74. > DOI: 10.7619/jcmp.20242568

XU Xinlong, LI Huan, MA Kaixuan. Correlations of the expression of silencing information regulatory factor 2-related enzyme-1 and colony-stimulating factor 1 receptors with clinical features and prognosis in patients with colon cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(23): 70-74. DOI: 10.7619/jcmp.20242568

Citation:

PDF (1730 KB)

Correlations of the expression of silencing information regulatory factor 2-related enzyme-1 and colony-stimulating factor 1 receptors with clinical features and prognosis in patients with colon cancer

the First Department of General Surgery, General Hospital of North China Petroleum Administration, Renqiu, Hebei, 062550

More Information

Received Date: June 17, 2024
Revised Date: September 01, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the correlations of the expression of silent information regulator 2 homolog 1 (SIRT1) and colony-stimulating factor 1 receptor (CSF1R) with the clinical characteristics and prognosis of patients with colon cancer.
Methods
Colon cancer tissue specimens and paracancer tissue specimens were collected from 148 patients with colon cancer. The clinical and pathological features of the patients were analyzed. Immunohistochemistry was used to detect the expression of SIRT1 and CSF1R; the Spearman's correlation analysis was employed to assess the correlation between SIRT1 and CSF1R; the Kaplan-Meier analysis was conducted to evaluate the associations of the expression of SIRT1 and CSF1R with patients' prognosis; the multivariate Cox regression analysis was performed to identify prognostic factors in colon cancer patients.
Results
Compared with the adjacent tissues, the expression of SIRT1 protein in colon cancer tissues was significantly decreased, and the expression of CSF1R protein was significantly increased (P < 0.05). The expressions of SIRT1 and CSF1R protein were correlated with lymph node metastasis, nerve invasion and invasion depth in patients with colon cancer (P < 0.05). The protein expressions of SIRT1 and CSF1R were negatively correlated (r=-0.536, P < 0.05). The 3-year survival rate of patients with high SIRT1 expression was significantly higher than that of patients with low SIRT1 expression (P < 0.05). The 3-year survival rate of patients with high CSF1R expression was significantly lower than that of patients with low CSF1R expression (P < 0.05). The 3-year survival rate of patients with high SIRT1 expression was significantly higher than that of patients with low SIRT1 expression (P < 0.05).
Conclusion
In colon cancer, SIRT1 expression is significantly downregulated, whereas CSF1R expression is upregulated, and both are closely related to the clinical and pathological features such as lymph node metastasis, neural invasion, and tumor infiltration depth. Detection of these biomarkers may have important value in predicting patients' prognosis and survival.
- silent information regulator 2 homolog 1,
- colony-stimulating factor 1 receptor,
- colon cancer,
- clinical characteristics,
- prognosis

FullText(HTML)

References (19)

References

[1]	RUAN H, LEIBOWITZ B J, ZHANG L, et al. Immunogenic cell death in colon cancer prevention and therapy[J]. Mol Carcinog, 2020, 59(7): 783-793. doi: 10.1002/mc.23183
[2]	齐荣暄, 刘格良, 穆俊芳, 等. 结肠癌免疫相关基因筛选和预后模型建立[J]. 实用临床医药杂志, 2023, 27(14): 63-71, 77. doi: 10.7619/jcmp.20231576
[3]	WEN J, MIN X J, SHEN M Q, et al. ACLY facilitates colon cancer cell metastasis by CTNNB1[J]. J Exp Clin Cancer Res, 2019, 38(1): 401. doi: 10.1186/s13046-019-1391-9
[4]	GUPTA R, BHATT L K, JOHNSTON T P, et al. Colon cancer stem cells: potential target for the treatment of colorectal cancer[J]. Cancer Biol Ther, 2019, 20(8): 1068-1082. doi: 10.1080/15384047.2019.1599660
[5]	ALVES-FERNANDES D K, JASIULIONIS M G. The role of SIRT1 on DNA damage response and epigenetic alterations in cancer[J]. Int J Mol Sci, 2019, 20(13): 3153. doi: 10.3390/ijms20133153
[6]	HAGAN N, KANE J L, GROVER D, et al. CSF1R signaling is a regulator of pathogenesis in progressive MS[J]. Cell Death Dis, 2020, 11(10): 904. doi: 10.1038/s41419-020-03084-7
[7]	LIU F T, BOUZNAD N, KALLER M, et al. Csf1r mediates enhancement of intestinal tumorigenesis caused by inactivation of Mir34a[J]. Int J Biol Sci, 2022, 18(14): 5415-5437. doi: 10.7150/ijbs.75503
[8]	中华人民共和国国家卫生和计划生育委员会. 结肠癌规范化诊疗指南(试行)[J]. 中国医学前沿杂志: 电子版, 2013, 5(8): 50-55. doi: 10.3969/j.issn.1674-7372.2013.08.011
[9]	ROSLAN N H, MAKPOL S, MOHD YUSOF Y A. A review on dietary intervention in obesity associated colon cancer[J]. Asian Pac J Cancer Prev, 2019, 20(5): 1309-1319. doi: 10.31557/APJCP.2019.20.5.1309
[10]	邓龙廉, 孙海滨, 恩日乐图, 等. 列线图预测结直肠癌淋巴结转移的研究进展[J]. 实用临床医药杂志, 2023, 27(5): 143-148. doi: 10.7619/jcmp.20223328
[11]	LI X Y, WEN D C, LI X K, et al. Identification of an immune signature predicting prognosis risk and lymphocyte infiltration in colon cancer[J]. Front Immunol, 2020, 11: 1678. doi: 10.3389/fimmu.2020.01678
[12]	YANG Y S, LIU Y, WANG Y W, et al. Regulation of SIRT1 and its roles in inflammation[J]. Front Immunol, 2022, 13: 831168. doi: 10.3389/fimmu.2022.831168
[13]	DASGUPTA A, SHUKLA S K, VERNUCCI E, et al. SIRT1-NOX4 signaling axis regulates cancer cachexia[J]. J Exp Med, 2020, 217(7): e20190745. doi: 10.1084/jem.20190745
[14]	AN Y F, WANG B, WANG X, et al. SIRT1 inhibits chemoresistance and cancer stemness of gastric cancer by initiating an AMPK/FOXO3 positive feedback loop[J]. Cell Death Dis, 2020, 11(2): 115. doi: 10.1038/s41419-020-2308-4
[15]	JUNG T Y, JIN G R, KOO Y B, et al. Deacetylation by SIRT1 promotes the tumor-suppressive activity of HINT1 by enhancing its binding capacity for β-catenin or MITF in colon cancer and melanoma cells[J]. Exp Mol Med, 2020, 52(7): 1075-1089. doi: 10.1038/s12276-020-0465-2
[16]	SPANGENBERG E, SEVERSON P L, HOHSFIELD L A, et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model[J]. Nat Commun, 2019, 10(1): 3758. doi: 10.1038/s41467-019-11674-z
[17]	RAO R, HAN R, OGUREK S, et al. Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition[J]. Neuro Oncol, 2022, 24(4): 584-597. doi: 10.1093/neuonc/noab228
[18]	CUI B, FAN X X, ZHOU D Z, et al. CSF1R methylation is a key regulatory mechanism of tumor-associated macrophages in hepatocellular carcinoma[J]. Oncol Lett, 2020, 20(2): 1835-1845. doi: 10.3892/ol.2020.11726
[19]	SHI X L, KALLER M, ROKAVEC M, et al. Characterization of a p53/miR-34a/CSF1R/STAT3 feedback loop in colorectal cancer[J]. Cell Mol Gastroenterol Hepatol, 2020, 10(2): 391-418. doi: 10.1016/j.jcmgh.2020.04.002